Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

100 trials found

Recruiting 999,999 target

Molecular Genetics Studies of Cancer Patients and Their Relatives

City of Hope Medical Center

NCT04185935

Recruiting 50,000 target

Rutgers University Study of the Genetics of Kidney Disease

Rutgers, The State University of New Jersey

NCT07217535

Recruiting 50,000 target

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

The Radiosurgery Society

NCT01885299

Recruiting 50,000 target

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Bayer

NCT06278207

Recruiting 40,000 target

Registry Study for Radiation Therapy Outcomes

Proton Collaborative Group

NCT01255748

Recruiting NA 36,503 target

Supraglottic Airway for Resuscitation Trial

Children's Hospital of Philadelphia

NCT07150923

Recruiting 25,000 target

Rutgers University Study of the Genetics of Breast Cancer.

Rutgers, The State University of New Jersey

NCT06773897

Recruiting 20,000 target

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Freenome Holdings

NCT06122077

Recruiting 10,000 target

Discarded Materials Study

Reproductive Medicine Associates of New Jersey

NCT01219335

Recruiting 10,000 target

Follow-up With Preimplantation Genetic Testing Patients

Genomic Prediction

NCT04477863

Recruiting 10,000 target

Innovations in Genicular Outcomes Registry

Pacira Pharmaceuticals

NCT05495334

Recruiting 10,000 target

Rutgers University Study of the Genetics of Pulmonary Hypertension

Rutgers, The State University of New Jersey

NCT07217522

Recruiting 10,000 target

CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management

Hackensack Meridian Health

NCT06804395

Recruiting NA 8,000 target

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

M.D. Anderson Cancer Center

NCT00539162

Recruiting 8,000 target

The Radiation Oncology Registry and Biosample Repository

Abramson Cancer Center at Penn Medicine

NCT01577251

Recruiting 6,550 target

Non-Invasive Preeclampsia Screening and Biobank

Sequenom

NCT06643741

Recruiting Phase 3 6,150 target

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Population Health Research Institute

NCT04774159

Recruiting NA 5,100 target

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

Population Health Research Institute

NCT05701358

Recruiting 5,000 target

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

Massachusetts General Hospital

NCT01696721

Recruiting 5,000 target

Effects of Oncological Treatment During Pregnancy on Mother and Child

University Hospital, Gasthuisberg

NCT00330447

Recruiting 5,000 target

Cardiogenic Shock Working Group Registry

Tufts Medical Center

NCT04682483

Recruiting 5,000 target

International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)

Montefiore Medical Center

NCT06174727

Recruiting Phase 3 4,390 target

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Merck Sharp & Dohme

NCT07044297

Recruiting 4,200 target

Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure

Impulse Dynamics

NCT07209098

Recruiting 4,000 target

EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)

Natera

NCT06808880

Recruiting Phase 3 4,000 target

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

University of Manitoba

NCT05848713

Recruiting Phase 3 4,000 target

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49

Vaxcyte

NCT07284654

Recruiting NA 3,290 target

Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

University of Rochester

NCT06543446

Recruiting 3,200 target

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

Memorial Sloan Kettering Cancer Center

NCT06370143

Recruiting Phase 4 3,200 target

Individualizing Treatment for Asthma in Primary Care (Full Study)

DARTNet Institute

NCT07052942

Recruiting NA 3,090 target

The ED-AWARENESS-2 Trial

Washington University School of Medicine

NCT05534243

Recruiting 3,000 target

Transitions of Care for Stroke Patients

Kiwon Lee MD

NCT06011720

Recruiting 3,000 target

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Center

NCT00579566

Recruiting 3,000 target

Spine Oncology Registry

Ohio State University Comprehensive Cancer Center

NCT07225491

Recruiting 3,000 target

A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease

Eisai Korea

NCT06810960

Recruiting NA 2,674 target

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

University of Utah

NCT05471908

Recruiting 2,500 target

Abbott Structural Heart Device Registry

Abbott Medical Devices

NCT06590467

Recruiting NA 2,400 target

Motiva Implants® Post-Approval Study

Motiva USA

NCT06938399

Recruiting NA 2,300 target

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Weill Medical College of Cornell University

NCT04124120

Recruiting NA 2,300 target

Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)

University of Pennsylvania

NCT05759988

Recruiting NA 2,039 target

Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe

Santiago Ortega Gutierrez

NCT06825897

Recruiting 2,020 target

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Guardant Health

NCT05059444

Recruiting NA 2,000 target

Wellness Program Outreach and Effectiveness

Massachusetts Institute of Technology

NCT06725511

Recruiting Phase 3 2,000 target

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Regeneron Pharmaceuticals

NCT07213778

Recruiting 2,000 target

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

Alnylam Pharmaceuticals

NCT07358078

Recruiting 2,000 target

Pancreatic Cancer Detection Consortium

City of Hope Medical Center

NCT06388967

Recruiting 2,000 target

Multiple Sclerosis Implementation Network (Registry)

The University of Texas Health Science Center, Houston

NCT07415824

Recruiting 2,000 target

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Stanford University

NCT02848274

Recruiting 2,000 target

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Sequenom

NCT01429389

Recruiting Phase 3 2,000 target

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Regeneron Pharmaceuticals

NCT07015905

Recruiting Phase 4 1,896 target

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

Memorial Sloan Kettering Cancer Center

NCT07308717

Recruiting 1,850 target

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

AstraZeneca

NCT06465810

Recruiting NA 1,750 target

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Memorial Sloan Kettering Cancer Center

NCT06954337

Recruiting 1,715 target

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Memorial Sloan Kettering Cancer Center

NCT04291612

Recruiting NA 1,605 target

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

Concept Medical

NCT06271590

Recruiting NA 1,600 target

StrokeNet Thrombectomy Endovascular Platform

Medical University of South Carolina

NCT06289985

Recruiting 1,500 target

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Peerbridge Health

NCT06699056

Recruiting 1,500 target

Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer

Memorial Sloan Kettering Cancer Center

NCT03922893

Recruiting NA 1,500 target

The HEARTFELT Study

Heartfelt Technologies

NCT06222099

Recruiting NA 1,440 target

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

Unity Health Toronto

NCT04754022

Recruiting 1,366 target

Collection of Information to Better Understand Young Onset Colorectal Cancer

Memorial Sloan Kettering Cancer Center

NCT04489238

Recruiting Phase 4 1,335 target

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Mayo Clinic

NCT06972056

Recruiting Phase 3 1,300 target

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Kura Oncology

NCT07007312

Recruiting Phase 2 1,260 target

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

BioNTech SE

NCT06712316

Recruiting 1,250 target

Lymphedema Surveillance Study

Memorial Sloan Kettering Cancer Center

NCT02743858

Recruiting NA 1,232 target

Empathic Communication Skills (ECS) Training

Memorial Sloan Kettering Cancer Center

NCT05456841

Recruiting Phase 3 1,220 target

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

AstraZeneca

NCT06921785

Recruiting Phase 3 1,216 target

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Bristol-Myers Squibb

NCT05827016

Recruiting 1,204 target

Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs

SpotitEarly

NCT07038785

Recruiting NA 1,200 target

The PEERLESS II Study

Inari Medical

NCT06055920

Recruiting 1,200 target

A Global Study of the PETAL Consortium

Massachusetts General Hospital

NCT06067347

Recruiting Phase 1 1,130 target

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Revolution Medicines

NCT06445062

Recruiting 1,100 target

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Rutgers, The State University of New Jersey

NCT02688517

Recruiting 1,065 target

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Merck Sharp & Dohme

NCT04165798

Recruiting NA 1,030 target

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

Johns Hopkins University

NCT06080698

Recruiting 1,025 target

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Memorial Sloan Kettering Cancer Center

NCT02296450

Recruiting 1,000 target

Terumo Aortic Global Endovascular Registry

Vascutek

NCT04246463

Recruiting NA 1,000 target

An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results

Memorial Sloan Kettering Cancer Center

NCT05420064

Recruiting 1,000 target

A Registry for People With T-cell Lymphoma

Memorial Sloan Kettering Cancer Center

NCT05978141

Recruiting 1,000 target

Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection

AI-Spectral

NCT07446582

Recruiting 1,000 target

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

United Therapeutics

NCT06388421

Recruiting Phase 3 1,000 target

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Merck Sharp & Dohme

NCT07060807

Recruiting 1,000 target

Male Infertility and Assisted Reproductive Technologies Research Biobank

Reproductive Medicine Associates of New Jersey

NCT06880302

Recruiting 1,000 target

Pivotal Study for the Cardiac Performance System (CPS)

Sensydia Corporation

NCT06870591

Recruiting 1,000 target

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

M.D. Anderson Cancer Center

NCT04739072

Recruiting Phase 3 1,000 target

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Bristol-Myers Squibb

NCT06561386

Recruiting 1,000 target

SuperSaturated Oxygen Comprehensive Observational Registry

TherOx

NCT06438315

Recruiting NA 1,000 target

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Pacific Edge Limited

NCT06394869

Recruiting 1,000 target

PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency

Inozyme Pharma

NCT06302439

Recruiting 1,000 target

Global Paradise System US Post Approval Study

ReCor Medical

NCT06297291

Recruiting 1,000 target

Germ Cell Tumor and Testicular Tumor DNA Registry

Memorial Sloan Kettering Cancer Center

NCT02099734

Recruiting Phase 4 1,000 target

Secukinumab Open Label Roll-over Extension Protocol

Novartis Pharmaceuticals

NCT04638647

Recruiting NA 1,000 target

A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

Cleerly

NCT06713239

Recruiting Phase 3 994 target

Prehospital Analgesia INtervention Trial (PAIN)

Jason Sperry

NCT05437575

Recruiting Phase 1 949 target

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

NCT04895709

Recruiting Phase 3 944 target

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Pfizer

NCT05020236

Recruiting Phase 1 933 target

A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

Regeneron Pharmaceuticals

NCT04626635

Recruiting Phase 1 930 target

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

Relay Therapeutics

NCT05216432

Recruiting 900 target

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Ascendis Pharma Endocrinology Division A/S

NCT05820672

Recruiting NA 900 target

Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention

University of Pittsburgh

NCT05748730

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →